85 related articles for article (PubMed ID: 17029219)
1. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
2. SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma.
Wan S; He QY; Yang Y; Liu F; Zhang X; Guo X; Niu H; Wang Y; Liu YX; Ye WL; Li XM; ZhuanSun XM; Sun P; He XS; Hu G; Breuhahn K; Zhao H; Wu GQ; Wu H
Cancer Res; 2024 Jun; 84(11):1872-1888. PubMed ID: 38471084
[TBL] [Abstract][Full Text] [Related]
3. A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth.
Viloria K; Munasinghe A; Asher S; Bogyere R; Jones L; Hill NJ
Sci Rep; 2016 Nov; 6():37839. PubMed ID: 27886258
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the matricellular concept.
Murphy-Ullrich JE; Sage EH
Matrix Biol; 2014 Jul; 37():1-14. PubMed ID: 25064829
[TBL] [Abstract][Full Text] [Related]
5. Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma.
Delany AM
Cancer Biol Ther; 2010 Jul; 10(1):65-7. PubMed ID: 20657168
[No Abstract] [Full Text] [Related]
6. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
7. SPARCL1 a novel player in cancer biology.
Gagliardi F; Narayanan A; Mortini P
Crit Rev Oncol Hematol; 2017 Jan; 109():63-68. PubMed ID: 28010899
[TBL] [Abstract][Full Text] [Related]
8. Diverse biological functions of the SPARC family of proteins.
Bradshaw AD
Int J Biochem Cell Biol; 2012 Mar; 44(3):480-8. PubMed ID: 22249026
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
Weaver M; Workman G; Schultz CR; Lemke N; Rempel SA; Sage EH
J Cell Biochem; 2011 Nov; 112(11):3093-102. PubMed ID: 21688302
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
Esposito I; Kayed H; Keleg S; Giese T; Sage EH; Schirmacher P; Friess H; Kleeff J
Neoplasia; 2007 Jan; 9(1):8-17. PubMed ID: 17325739
[TBL] [Abstract][Full Text] [Related]
11. Secretome profiling of
Kauser S; Mughees M; Mangangcha IR; Swami S; Wajid S
Front Oncol; 2023; 13():1209168. PubMed ID: 37719007
[TBL] [Abstract][Full Text] [Related]
12. SPARC: a potential target for functional nanomaterials and drugs.
Jiang S; Sun HF; Li S; Zhang N; Chen JS; Liu JX
Front Mol Biosci; 2023; 10():1235428. PubMed ID: 37577749
[TBL] [Abstract][Full Text] [Related]
13. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder.
Nuñez-delMoral A; Bianchi PC; Brocos-Mosquera I; Anesio A; Palombo P; Camarini R; Cruz FC; Callado LF; Vialou V; Erdozain AM
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830603
[TBL] [Abstract][Full Text] [Related]
14. Immunological role and prognostic value of SPARCL1 in pan-cancer analysis.
He K; Li C; Yuan H; Jiang K; Deng G
Pathol Oncol Res; 2022; 28():1610687. PubMed ID: 36483097
[No Abstract] [Full Text] [Related]
15. Association of serum secreted protein acidic and rich in cysteine-like protein 1 with metabolic measures and dyslipidemia among Chinese adults.
Hu C; Wang S; Lin L; Qi H; Lin H; Jia X; Zhu Y; Wu X; Li M; Wang T; Zhao Z; Xu M; Xu Y; Wang W; Ning G; Bi Y; Li D; Chen Y; Dai M; Lu J
Front Endocrinol (Lausanne); 2022; 13():1018657. PubMed ID: 36387870
[TBL] [Abstract][Full Text] [Related]
16. The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.
Atorrasagasti C; Onorato AM; Mazzolini G
J Physiol Biochem; 2023 Nov; 79(4):815-831. PubMed ID: 36018492
[TBL] [Abstract][Full Text] [Related]
17. Circular_0086414 induces SPARC like 1 (
Jiang Q; Wang H; Yuan D; Qian X; Ma X; Yan M; Xing W
Bioengineered; 2022 May; 13(5):12099-12114. PubMed ID: 35549806
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis.
Shi S; Ma HY; Han XY; Sang YZ; Yang MY; Zhang ZG
Biomed Res Int; 2022; 2022():8600419. PubMed ID: 35211625
[TBL] [Abstract][Full Text] [Related]
19. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
[TBL] [Abstract][Full Text] [Related]
20. A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Tang Y; Wu Y; Xue M; Zhu B; Fan W; Li J
J Oncol; 2022; 2022():3822773. PubMed ID: 35111225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
